116 related articles for article (PubMed ID: 8732768)
1. Preliminary crystallographic studies of an anti-HIV-1 protease antibody that inhibits enzyme activity.
Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
Protein Sci; 1996 May; 5(5):966-8. PubMed ID: 8732768
[TBL] [Abstract][Full Text] [Related]
2. Anti-HIV proteinase monoclonal antibody F11.2.32 that inhibits enzyme activity.
Stouracova R; Lescar J; Brynda J; Riottot MM; Chitarra V; Fabry M; Horejsi M; Rezacova P; Bentley G; Sedlacek J
Gen Physiol Biophys; 1998 Jun; 17 Suppl 1():6-8. PubMed ID: 9789741
[No Abstract] [Full Text] [Related]
3. Inhibition of HIV protease by monoclonal antibodies.
Rezacova P; Brynda J; Fabry M; Horejsi M; Stouracova R; Lescar J; Chitarra V; Riottot MM; Sedlacek J; Bentley GA
J Mol Recognit; 2002; 15(5):272-6. PubMed ID: 12447903
[TBL] [Abstract][Full Text] [Related]
4. Structural studies of HIV-1 protease-inhibiting antibodies.
Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
Gen Physiol Biophys; 1998 Jun; 17 Suppl 1():3-6. PubMed ID: 9789740
[No Abstract] [Full Text] [Related]
5. Crystal structure of a cross-reaction complex between an anti-HIV-1 protease antibody and an HIV-2 protease peptide.
Rezacova P; Brynda J; Lescar J; Fabry M; Horejsi M; Sieglova I; Sedlacek J; Bentley GA
J Struct Biol; 2005 Mar; 149(3):332-7. PubMed ID: 15721587
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional structure of an Fab-peptide complex: structural basis of HIV-1 protease inhibition by a monoclonal antibody.
Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
J Mol Biol; 1997 Apr; 267(5):1207-22. PubMed ID: 9150407
[TBL] [Abstract][Full Text] [Related]
7. Crystallization, sequence, and preliminary crystallographic data for an antipeptide Fab 50.1 and peptide complexes with the principal neutralizing determinant of HIV-1 gp120.
Stura EA; Stanfield RL; Fieser GG; Silver S; Roguska M; Hincapie LM; Simmerman HK; Profy AT; Wilson IA
Proteins; 1992 Dec; 14(4):499-508. PubMed ID: 1438187
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody Fab fragment crystallized with and without a peptide epitope from HIV.
Pfeffer-Hennig S; Wessner H; Hennig M; Dauter Z; Hausdorf G; Höhne WE
Proteins; 1993 Aug; 16(4):437-9. PubMed ID: 7689218
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the HIV-1 and HIV-2 proteases by a monoclonal antibody.
Lescar J; Brynda J; Rezacova P; Stouracova R; Riottot MM; Chitarra V; Fabry M; Horejsi M; Sedlacek J; Bentley GA
Protein Sci; 1999 Dec; 8(12):2686-96. PubMed ID: 10631984
[TBL] [Abstract][Full Text] [Related]
10. Human antibodies to HIV-1 by recombinant DNA methods.
Burton DR; Barbas CF
Chem Immunol; 1993; 56():112-26. PubMed ID: 8452652
[No Abstract] [Full Text] [Related]
11. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF
J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of HIV-1 and HIV-2 protease inhibition by a monoclonal antibody.
Rezacova P; Lescar J; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
Structure; 2001 Oct; 9(10):887-95. PubMed ID: 11591344
[TBL] [Abstract][Full Text] [Related]
13. Structure of a single-chain Fv fragment of an antibody that inhibits the HIV-1 and HIV-2 proteases.
Lescar J; Brynda J; Fabry M; Horejsi M; Rezacova P; Sedlacek J; Bentley GA
Acta Crystallogr D Biol Crystallogr; 2003 May; 59(Pt 5):955-7. PubMed ID: 12777823
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of drug-resistant HIV protease variants by monoclonal antibodies.
Bartonová V; Král V; Sieglová I; Brynda J; Fábry M; Horejsí M; Kozísek M; Sasková KG; Konvalinka J; Sedlácek J; Rezácová P
Antiviral Res; 2008 Jun; 78(3):275-7. PubMed ID: 18329737
[TBL] [Abstract][Full Text] [Related]
15. Structural studies of human HIV-1 V3 antibodies.
Stanfield RL; Wilson IA
Hum Antibodies; 2005; 14(3-4):73-80. PubMed ID: 16720977
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel CD4i human monoclonal antibody Fab that neutralizes HIV-1 primary isolates from different clades.
Zhang MY; Shu Y; Sidorov I; Dimitrov DS
Antiviral Res; 2004 Mar; 61(3):161-4. PubMed ID: 15168796
[TBL] [Abstract][Full Text] [Related]
17. Reactivity-based one-pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody.
Lee HK; Scanlan CN; Huang CY; Chang AY; Calarese DA; Dwek RA; Rudd PM; Burton DR; Wilson IA; Wong CH
Angew Chem Int Ed Engl; 2004 Feb; 43(8):1000-3. PubMed ID: 14966891
[No Abstract] [Full Text] [Related]
18. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
19. Preliminary crystallographic analysis of a Fab specific for P-glycoprotein with and without bound peptide.
Vasudevan S; Johns KL; Rose DR
J Mol Biol; 1994 Sep; 241(5):736-8. PubMed ID: 7915332
[TBL] [Abstract][Full Text] [Related]
20. The chimeric mouse-human anti-CD4 Fab 13B8.2 expressed in baculovirus inhibits both antigen presentation and HIV-1 promoter activation.
Bès C; Cerutti M; Briant-Longuet L; Bresson D; Peraldi-Roux S; Pugnière M; Mani JC; Pau B; Devaux C; Granier C; Devauchelle G; Chardès T
Hum Antibodies; 2001; 10(2):67-76. PubMed ID: 11673661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
